Skip to main content
. 2017 Sep 4;7:10352. doi: 10.1038/s41598-017-09678-0

Figure 6.

Figure 6

Kaplan-Meier survival curves for responding (R) and non-responding (NR) patients. Patients were classified with cross validation using the optimal QUS feature sets acquired at weeks 1, 4, and 8, and also based on the histopathology at post-treatment.